Perspective Therapeutics, Inc. (CATX)
USD 2.31
(7.71%)
USD 2.31
(7.71%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 17.42 Million USD | 45.13% |
| 2021 | 12 Million USD | 40.3% |
| 2020 | 8.55 Million USD | -0.49% |
| 2019 | 8.6 Million USD | 3.3% |
| 2018 | 8.32 Million USD | -2.87% |
| 2017 | 8.57 Million USD | 19.96% |
| 2016 | 7.14 Million USD | 37.11% |
| 2015 | 5.21 Million USD | 15.71% |
| 2014 | 4.5 Million USD | 2.55% |
| 2013 | 4.39 Million USD | 4.13% |
| 2012 | 4.21 Million USD | -1.95% |
| 2011 | 4.3 Million USD | 4.39% |
| 2010 | 4.12 Million USD | -12.97% |
| 2009 | 4.73 Million USD | -22.6% |
| 2008 | 6.11 Million USD | -29.29% |
| 2007 | 8.65 Million USD | -10.31% |
| 2006 | 9.64 Million USD | 79.46% |
| 2005 | 5.37 Million USD | 0.0% |
| 2003 | 9095.00 USD | -52.19% |
| 2002 | 19.02 Thousand USD | 150.82% |
| 2001 | 7584.00 USD | -51.29% |
| 2000 | 15.56 Thousand USD | 10.04% |
| 1999 | 14.14 Thousand USD | -8.89% |
| 1998 | 15.53 Thousand USD | -93.03% |
| 1997 | 222.82 Thousand USD | -84.37% |
| 1996 | 1.42 Million USD | -50.94% |
| 1995 | 2.9 Million USD | 76.06% |
| 1994 | 1.65 Million USD | 7.43% |
| 1993 | 1.53 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q1 | 10.99 Million USD | -0.34% |
| 2022 Q3 | 11.45 Million USD | 217.78% |
| 2022 Q1 | 4.62 Million USD | 52.44% |
| 2022 Q2 | 3.6 Million USD | -21.98% |
| 2022 FY | 17.42 Million USD | 45.13% |
| 2022 Q4 | 11.03 Million USD | -3.71% |
| 2021 Q3 | 2.81 Million USD | -1.33% |
| 2021 Q1 | 3.3 Million USD | 35.42% |
| 2021 FY | 12 Million USD | 40.3% |
| 2021 Q4 | 3.03 Million USD | 7.63% |
| 2021 Q2 | 2.85 Million USD | -13.56% |
| 2020 Q3 | 2.12 Million USD | 4.57% |
| 2020 Q2 | 2.03 Million USD | 3.72% |
| 2020 Q1 | 1.96 Million USD | -13.27% |
| 2020 FY | 8.55 Million USD | -0.49% |
| 2020 Q4 | 2.43 Million USD | 14.72% |
| 2019 Q3 | 2.25 Million USD | 11.92% |
| 2019 FY | 8.6 Million USD | 3.3% |
| 2019 Q1 | 2.07 Million USD | 2.42% |
| 2019 Q2 | 2.01 Million USD | -2.8% |
| 2019 Q4 | 2.26 Million USD | 0.27% |
| 2018 Q1 | 2.04 Million USD | -27.25% |
| 2018 Q2 | 2.21 Million USD | 8.57% |
| 2018 Q3 | 2.04 Million USD | -7.85% |
| 2018 Q4 | 2.02 Million USD | -0.98% |
| 2018 FY | 8.32 Million USD | -2.87% |
| 2017 Q3 | 1.94 Million USD | -2.55% |
| 2017 FY | 8.57 Million USD | 19.96% |
| 2017 Q2 | 1.99 Million USD | 10.02% |
| 2017 Q1 | 1.81 Million USD | -23.04% |
| 2017 Q4 | 2.8 Million USD | 44.1% |
| 2016 Q1 | 1.62 Million USD | 34.53% |
| 2016 FY | 7.14 Million USD | 37.11% |
| 2016 Q4 | 2.36 Million USD | 40.37% |
| 2016 Q3 | 1.68 Million USD | 13.8% |
| 2016 Q2 | 1.47 Million USD | -8.93% |
| 2015 FY | 5.21 Million USD | 15.71% |
| 2015 Q4 | 1.2 Million USD | -13.42% |
| 2015 Q3 | 1.39 Million USD | -3.07% |
| 2015 Q2 | 1.43 Million USD | 22.43% |
| 2015 Q1 | 1.17 Million USD | -10.29% |
| 2014 Q2 | 982.35 Thousand USD | -11.2% |
| 2014 Q1 | 1.1 Million USD | -8.04% |
| 2014 Q4 | 1.3 Million USD | 18.31% |
| 2014 FY | 4.5 Million USD | 2.55% |
| 2014 Q3 | 1.1 Million USD | 12.61% |
| 2013 Q2 | 1.02 Million USD | -11.38% |
| 2013 FY | 4.39 Million USD | 4.13% |
| 2013 Q1 | 1.15 Million USD | -0.6% |
| 2013 Q4 | 1.2 Million USD | 20.18% |
| 2013 Q3 | 1 Million USD | -2.39% |
| 2012 Q1 | 1.1 Million USD | -6.13% |
| 2012 FY | 4.21 Million USD | -1.95% |
| 2012 Q3 | 1.01 Million USD | 7.35% |
| 2012 Q2 | 940.82 Thousand USD | -14.65% |
| 2012 Q4 | 1.16 Million USD | 15.26% |
| 2011 FY | 4.3 Million USD | 4.39% |
| 2011 Q3 | 967.07 Thousand USD | -2.41% |
| 2011 Q4 | 1.17 Million USD | 21.44% |
| 2011 Q1 | 1.16 Million USD | -4.43% |
| 2011 Q2 | 990.94 Thousand USD | -15.21% |
| 2010 Q1 | 1.08 Million USD | -14.27% |
| 2010 FY | 4.12 Million USD | -12.97% |
| 2010 Q2 | 912.43 Thousand USD | -15.83% |
| 2010 Q3 | 1.05 Million USD | 15.17% |
| 2010 Q4 | 1.22 Million USD | 16.37% |
| 2009 FY | 4.73 Million USD | -22.6% |
| 2009 Q1 | 1.11 Million USD | -7.48% |
| 2009 Q3 | 1.14 Million USD | -5.79% |
| 2009 Q4 | 1.26 Million USD | 10.64% |
| 2009 Q2 | 1.21 Million USD | 8.87% |
| 2008 Q2 | 1.68 Million USD | -2.54% |
| 2008 FY | 6.11 Million USD | -29.29% |
| 2008 Q1 | 1.72 Million USD | -3.01% |
| 2008 Q4 | 1.2 Million USD | -19.6% |
| 2008 Q3 | 1.49 Million USD | -11.13% |
| 2007 Q2 | 2.45 Million USD | 10.79% |
| 2007 Q1 | 2.21 Million USD | -21.92% |
| 2007 Q4 | 1.78 Million USD | -18.66% |
| 2007 FY | 8.65 Million USD | -10.31% |
| 2007 Q3 | 2.19 Million USD | -10.79% |
| 2006 Q4 | 2.84 Million USD | 27.7% |
| 2006 Q2 | 1.92 Million USD | -27.3% |
| 2006 Q1 | 2.65 Million USD | 46.56% |
| 2006 FY | 9.64 Million USD | 79.46% |
| 2006 Q3 | 2.22 Million USD | 15.41% |
| 2005 Q3 | 1.15 Million USD | 3.39% |
| 2005 Q2 | 1.11 Million USD | -14.52% |
| 2005 Q4 | 1.8 Million USD | 57.26% |
| 2005 FY | 5.37 Million USD | 0.0% |
| 2005 Q1 | 1.3 Million USD | 0.0% |
| 2004 Q2 | 3574.00 USD | -14.27% |
| 2004 Q3 | 302.04 Thousand USD | 8351.04% |
| 2004 Q1 | 4169.00 USD | -44.21% |
| 2003 Q2 | 2934.00 USD | -57.91% |
| 2003 FY | 9095.00 USD | -52.19% |
| 2003 Q3 | 1593.00 USD | -45.71% |
| 2003 Q1 | 6971.00 USD | 292.95% |
| 2003 Q4 | 7472.00 USD | 369.05% |
| 2002 Q3 | 2708.00 USD | -64.23% |
| 2002 FY | 19.02 Thousand USD | 150.82% |
| 2002 Q1 | -271.00 USD | -118.3% |
| 2002 Q2 | 7570.00 USD | 2893.36% |
| 2002 Q4 | 1774.00 USD | -34.49% |
| 2001 Q2 | 1495.00 USD | -11.64% |
| 2001 Q3 | 4879.00 USD | 226.35% |
| 2001 Q4 | 1481.00 USD | -69.65% |
| 2001 Q1 | 1692.00 USD | -84.41% |
| 2001 FY | 7584.00 USD | -51.29% |
| 2000 Q4 | 10.85 Thousand USD | 1012.82% |
| 2000 Q2 | 2054.00 USD | -85.41% |
| 2000 Q1 | 14.07 Thousand USD | 58558.33% |
| 2000 FY | 15.56 Thousand USD | 10.04% |
| 2000 Q3 | 975.00 USD | -52.53% |
| 1999 Q3 | 25.00 USD | 4.17% |
| 1999 FY | 14.14 Thousand USD | -8.89% |
| 1999 Q4 | 24.00 USD | -4.0% |
| 1999 Q1 | 12.57 Thousand USD | 1622.33% |
| 1999 Q2 | 24.00 USD | -99.81% |
| 1998 Q2 | 2690.00 USD | 0.0% |
| 1998 Q3 | 463.00 USD | -82.79% |
| 1998 Q4 | 730.00 USD | 57.67% |
| 1998 FY | 15.53 Thousand USD | -93.03% |
| 1997 FY | 222.82 Thousand USD | -84.37% |
| 1996 FY | 1.42 Million USD | -50.94% |
| 1995 FY | 2.9 Million USD | 76.06% |
| 1994 FY | 1.65 Million USD | 7.43% |
| 1993 FY | 1.53 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Electromed, Inc. | 35.14 Million USD | 50.417% |
| Senseonics Holdings, Inc. | 78.69 Million USD | 77.856% |
| Catheter Precision, Inc. | 15.52 Million USD | -12.266% |
| Xtant Medical Holdings, Inc. | 65.62 Million USD | 73.446% |